Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humansM Mas, M Farré, R de la Torre, et al.
Revista Clinica Espanola|July 1, 1992
[Determination of glycosylated hemoglobin in clinical practice care of diabetes]M González Rivera, A Pedromingo Marino, E Guardiola Pereira, et al.
Drug and Alcohol Dependence|October 24, 2001
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy malesP N Roset, M Farré, R de la Torre, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 18, 1999
Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detectionJ Ortuño, N Pizarro, M Farré, et al.
British Journal of Clinical Pharmacology|February 15, 2000
Non-linear pharmacokinetics of MDMA ('ecstasy') in humansR de la Torre, M Farré, J Ortuño, et al.
American Journal of Clinical Oncology|July 28, 2001
Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma of unknown primary site: a phase II trialE Guardiola, X Pivot, X Tchicknavorian, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolismM Farré, R de la Torre, M L González, et al.
Psychopharmacology|November 13, 2012
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apartA M Peiró, M Farré, P N Roset, et al.
Psychopharmacology|April 9, 2004
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokineticsM Farré, R de la Torre, B O Mathúna, et al.
Pageof 8